Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Rectal adenocarcinoma
ADR ID BADD_A07632
ADR Hierarchy
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.05      Malignant anorectal neoplasms
07.21.05.005      Rectal adenocarcinoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.13      Gastrointestinal neoplasms malignant and unspecified
16.13.01      Colorectal neoplasms malignant
16.13.01.016      Rectal adenocarcinoma
Description Not Available
MedDRA Code 10038019
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Rectal adenocarcinoma | Rectal adenocarcinoma Dukes A | Rectal adenocarcinoma Dukes B1 | Rectal adenocarcinoma Dukes B2 | Rectal adenocarcinoma Dukes C | Rectal adenocarcinoma Dukes D | Rectal adenocarcinoma recurrent | Rectal adenocarcinoma stage I | Rectal adenocarcinoma stage II | Rectal adenocarcinoma stage III | Rectal adenocarcinoma stage IV | Rectal adenocarcinoma stage unspecified | Metastatic rectal adenocarcinoma
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00151Apixaban0.000087%
BADD_D01252Leflunomide0.000428%
BADD_D01253Lenalidomide0.000844%
BADD_D01913Ranitidine--
BADD_D01922Regorafenib0.000392%
BADD_D02373Warfarin0.000028%
BADD_D02464Fingolimod0.000482%
The 1th Page    1    Total 1 Pages